RHA Redensity™
Introducing a groundbreaking solution approved by the FDA, tailored for addressing dynamic perioral rhytids through injection into both the superficial dermis and dermis layers.
Ideal for patients seeking correction with a filler placed superficially in the dermis while aiming for a natural appearance devoid of any undesirable heaviness. The results are noteworthy, with effects lasting for a substantial period of up to 12 months*.
In a case study, a patient underwent treatment with 0.3 mL of RHA Redensity™ for perioral rhytids, alongside 1.9 mL of RHA® 3, distributed for direct nasolabial fold correction, marionette lines, and oral commissures, and 1.6 mL of RHA® 4 for indirect nasolabial fold correction. Images taken before and two weeks post-treatment showcased notable improvements, although individual outcomes may differ.
The RHA Redensity™ injection is specifically designed for adults aged 22 or older, targeting moderate to severe dynamic perioral rhytids. Administered with a thin gauge needle (30 G x ½”), it is inserted into the superficial dermis or dermis using techniques such as serial puncture, linear threading, or fanning, ensuring precise delivery with the needle bevel angled at 5° to 15° to the skin surface.
For more information visit rha.revanceaesthetics.com
RHA® 2
Tailored to meet the needs of patients aiming to address specific concerns like radial cheek lines while achieving a natural, soft-focus appearance that lasts impressively long.
A case study featured a patient treated with 3.2 mL of RHA® 2, with allocations including direct nasolabial fold correction, indirect nasolabial fold correction, perioral rhytids, marionette lines, oral commissures, and radial cheek lines. Before-and-after images captured significant improvements within two weeks of treatment, though outcomes may vary from person to person.
RHA® 2 injection targets moderate to severe dynamic facial wrinkles and folds, including nasolabial folds, in individuals aged 22 years or older. Administered with a thin gauge needle (30 G x ½”), it is precisely inserted into the mid-to-deep dermis at an approximate angle of 15° to 30° parallel to the length of the wrinkle or fold, ensuring accurate delivery for optimal results.
For more information visit rha.revanceaesthetics.com
RHA® 3
Suitable for patients seeking correction in areas like marionette lines and oral commissures, who desire a natural appearance with a moderately robust filler offering seamless results that endure for an impressive duration of up to 15 months*.
In a specific case, a patient underwent treatment with 2.3 mL of RHA® 3, allocated for direct and indirect nasolabial fold correction, along with enhancement in oral commissures. Before-and-after images captured significant improvements within two weeks of the procedure, acknowledging the potential variance in individual outcomes.
RHA® 3 injection is designed for individuals aged 22 years or older, targeting moderate to severe dynamic facial wrinkles and folds, including nasolabial folds. Administered with a thin gauge needle (27 G x ½”), it is precisely inserted into the mid-to-deep dermis at an angle of approximately 15° to 30° parallel to the length of the wrinkle or fold, ensuring accurate placement for optimal correction.
For more information visit rha.revanceaesthetics.com
RHA® 4
Tailored for patients seeking correction with a deeper-placed filler, aiming for a natural appearance with added volume while avoiding noticeable ridges.
In a notable case, a patient received 3.6 mL of RHA® 4, strategically distributed for direct and indirect nasolabial fold correction, along with enhancements in oral commissures. Before-and-after images depicted significant improvements within two weeks post-treatment, noting the potential variability in individual responses.
RHA® 4 injection is specifically designed for individuals aged 22 years or older, addressing moderate to severe dynamic facial wrinkles and folds, including nasolabial folds. Administered with a thin gauge needle (27 G x ½”) or a cannula (25 G x 2″), it is precisely inserted into the deep dermis to superficial subcutaneous tissue at an angle of approximately 15° to 30° with a needle and 30° with a cannula, ensuring precise placement for optimal correction.
For more information visit rha.revanceaesthetics.com
We provide state-of-the-art treatments and services to make your health and aesthetic goals a reality. As a team, it is our priority to help you achieve your dreams.
We offer a complimentary consultation for all of our services.
